Science and Enterprise

Tag: biotechnology

  • Patients Get Lab-Grown Blood Vessels From Donor Skin Cells

    For the first time, according to the American Heart Association, human blood vessels grown in the lab from donor skin cells have been successfully implanted into patients. The findings were presented today (27 June) in the American Heart Association’s Emerging Science Series webinar. The research involves the work of Cytograft Tissue Engineering Inc. in Novato,…

  • Genentech Gets Rights, Can Buy Out Biotech Research Program

    The biotechnology company Forma Therapeutics in Cambridge, Massachusetts says it has an agreement with Genentech, a member of the Roche Group, granting Genentech exclusive rights to acquire one of Forma’s pre-clinical small molecule cancer research programs. The specific cancer target of the therapy under development is not disclosed. The agreement begins as a research collaboration…

  • Genomic Software Offers Faster Interpretations for Diagnosis

    Software developed by scientists from University of Utah in Salt Lake City and Omicia Inc. in Emeryville, California, improves the speed and ability to identify and interpret genetic variations for the diagnosis of disease. The researchers that developed the software describe their findings in the current issue of the journal Genome Research. The team led…

  • Audion, Sanofi to Partner on Hearing Loss Therapies

    The French pharmaceutical company Sanofi and biotechnology company Audion Therapeutics in Amsterdam have agreed to develop potential treatments for hearing loss through through regenerative medicine and biologics. The collaboration will build on technology developed by Audion’s co-founder Albert Edge at the Massachusetts Eye and Ear Infirmary in Boston. Audion originally licensed Edge’s technology from Mass…

  • New Analytical Tools Reveal Cancer DNA Properties

    Researchers from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project developed a computerized algorithm to better identify genomic properties of cancer cells. Their findings appear in the advance online issue of the journal Nature Methods (paid subscription required). The analytical methods are contained in a software package called Clipping Reveals…

  • Collaboration to Develop Second-Generation Malaria Vaccine

    The PATH Malaria Vaccine Initiative (MVI) says it has an agreement with Dutch biopharmaceutical company Crucell N.V., a division of Johnson & Johnson, and GlaxoSmithKline (GSK) to develop a second-generation vaccine against malaria. PATH is an international non-profit organization that helps communities worldwide break longstanding cycles of poor health. According to World Health Organization (WHO),…

  • Stem Cell Bandage Approved for Clinical Trial

    The U.K.’s Medicines and Healthcare products Regulatory Agency approved for clinical trial a new type of stem cell bandage to treat torn knee cartilage. The experimental bandage is made by Azellon Ltd, a spin-off company from University of Bristol in the U.K. The bandage developed by Azellon repairs torn meniscal cartilage in the knee, a…

  • NIH Approves Two Human Embryonic Stem Cell Lines

    BioTime Inc., a biotechnology company in Alameda, California, says that two human embryonic stem (hES) cell lines developed by a subsidiary have been approved by National Institutes of Health (NIH) for the NIH Human Embryonic Stem Cell Registry. Approval by NIH allows the use of these cell lines in federally funded research; only hES cell…

  • Diagnostic Company to Partner with Scripps on Drug Discovery

    Molecular Response, a diagnostic services company in San Diego, California says it has an agreement with Scripps Genomic Medicine, part of the Scripps Translational Science Institute also in San Diego, for joint discovery of oncology and cardiovascular drugs. Molecular Response develops molecular diagnostics as a companion to targeted and personalized therapeutics. Under the terms of…

  • Engineers Build Compact Diagnostic Biosensor

    Engineers at Vanderbilt University in Nashville, Tennessee have developed a small silicon-based sensor for medical diagnostics and detecting toxins. Their findings appear in current issue of the journal Optics Express. The sensor was originally designed to detect particular DNA sequences, which can be helpful in identifying if a person is predisposed to disorders or conditions…